IPO

HMH Holding Inc.'s Q2 results reveal a calculated strategy: using its IPO to fortify its balance sheet while betting on digital tech to outmaneuver market headwinds.

A new $105M SPAC enters the fray. We examine its veteran leadership, its cross-sector strategy, and what it takes to win in today's SPAC market.

Fueled by SpaceX's blockbuster IPO and a stake in a new Jeff Bezos venture, Stack Capital’s Q2 gain offers a rare, liquid window into private tech.

Attovia Therapeutics’ successful IPO injects massive capital into its ambitious pipeline, but can its novel multi-specific antibody platform outmaneuver giants?

Amid a biotech funding revival, Twist's upsized $300M deal signals a bold move to expand its synthetic biology platform, fueling a high-stakes investor debate.

With promising copper data from its Vent Property, Northern Discovery Metals' phased strategy signals a mature approach to junior exploration.

Newly-listed GoldInxs is wasting no time, using its $1.54M IPO to fund an advanced 3D survey on a BC property with 'Blackwater-style' potential.

Strong Q2 results, pivotal deals with AstraZeneca and MSK, and a clear path to profitability signal SOPHiA GENETICS is converting its AI platform into market leadership.

IDEAYA Biosciences advances its breakthrough melanoma drug toward FDA review while its $1.24B cash runway fuels a deep pipeline targeting cancer's toughest codes.

Cohen & Company's Q2 results showcase its mastery of the resurgent SPAC market. With revenue soaring to $69.5M and major deals inked, the boutique firm proves that specialized expertise can deliver outsized returns.

Fresh off a $260M IPO, Seaport Therapeutics is advancing a de-risked pipeline for depression and anxiety, leveraging its novel platform to unlock new potential.

Green Bridge's C$4M capital raise signals investor confidence in its Minnesota copper and nickel projects, vital for the US green energy supply chain.

As ARKO Corp. preps its Q2 report, all eyes are on whether its recent strategic overhaul, including the IPO of its fuel arm, can deliver growth.

South Korean robotic hand specialist Tesollo targets a post-2027 IPO, fueled by strategic Series B funding and a mission to dominate industrial automation.

Forbright's first public earnings report was clouded by one-time costs, but a deeper look reveals a potent digital deposit platform and specialized lending model.

The sandwich giant's IPO isn't just about cashing in. It's a strategic move to fund global expansion and dominate a fiercely competitive fast-casual market.

Catalyst Acquisition Corp. has closed its $200M IPO. Led by media veterans, the SPAC is now on the hunt for a major deal in the booming gaming and media sectors.

CleanCore Solutions signs a massive AI data center deal worth up to $3B, marking a high-stakes pivot from its eclectic past into the AI infrastructure gold rush.

Hong Kong's Everbright Digital secured new funds for its metaverse ambitions, but a closer look at the deal reveals the harsh realities facing small-cap tech firms.

Hercules Capital's new $325M debt offering isn't just a balance sheet move. It's a strategic reload to fund the next wave of tech and life science innovators.